{"id":18890,"date":"2021-09-29T10:21:15","date_gmt":"2021-09-29T14:21:15","guid":{"rendered":"https:\/\/medicarereport.org\/?p=18890"},"modified":"2021-09-29T10:21:15","modified_gmt":"2021-09-29T14:21:15","slug":"alzheimers-drug-targets-people-with-mild-cognitive-impairment-what-does-that-mean","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=18890","title":{"rendered":"Alzheimer\u2019s Drug Targets People With Mild Cognitive Impairment. What Does That Mean?"},"content":{"rendered":"<p>(By Judith Graham for Kaiser Health News)<\/p>\n<p>The approval of a controversial new drug for Alzheimer\u2019s disease, Aduhelm, is shining a spotlight on mild cognitive impairment \u2014 problems with memory, attention, language or other cognitive tasks that exceed changes expected with normal aging.<\/p>\n<p>After initially indicating that Aduhelm could be prescribed to anyone with dementia, the Food and Drug Administration now specifies that the prescription drug be given to individuals with mild cognitive impairment or early-stage Alzheimer\u2019s, the groups in which the medication was studied.\u00a0 Continue reading the article <a href=\"https:\/\/khn.org\/news\/article\/alzheimers-drug-targets-people-with-mild-cognitive-impairment-what-does-that-mean\/\">here&#8230;<\/a><\/p>\n<p>Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation<\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-899\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png\" alt=\"\" width=\"300\" height=\"156\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-1024x533.png 1024w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png 1600w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Judith Graham for Kaiser Health News) The approval of a controversial new drug for Alzheimer\u2019s disease, Aduhelm, is shining<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18,26,31,15],"tags":[],"class_list":["post-18890","post","type-post","status-publish","format-standard","hentry","category-aging","category-alzheimersdementia","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18890"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18890\/revisions"}],"predecessor-version":[{"id":18891,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/18890\/revisions\/18891"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}